866-997-4948(US-Canada Toll Free)

Drug Eluting Balloons (DEB) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Published By :

GlobalData

Published Date : Dec 2011

Category :

Surgical Equipment

No. of Pages : 91 Pages



GlobalDatas new report, Drug Eluting Balloons (DEB) Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 provides key data, information and analysis on the global drug eluting balloons market. The report provides market landscape, competitive landscape and market trends information on the drug eluting balloons market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the markets dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Key geographies covered include Germany, France, Italy, the UK, Spain, China, Australia and India.
  • Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
  • Qualitative analysis of key market trends, market drivers, and restraints within the drug eluting balloons market. 
  • The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies. 
  • Key players covered include B Braun, Eurocor and Invatec. 
Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the drug eluting balloons globally.
  • Design and develop your product development, marketing and sales strategies.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
  • Whats the next big thing in the drug eluting balloons market landscape? Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global drug eluting balloons market and the factors shaping it.
Table of Content

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6

2 Introduction 7
2.1 GlobalData Report Guidance 7

3 Major Cardiovascular Indications Approved for Drug Eluting Balloons 8
3.1 In-Stent Restenosis 8
3.1.1 Introduction 8
3.1.2 Pathophysiology 8
3.1.3 Etiology - Risk Factors 9
3.2 In-Stent Restenosis Epidemiology - Global 10
3.2.1 Treatment Flow Model 10
3.3 Peripheral Vascular Disease - Overview and Pathophysiology 12
3.3.1 Introduction 12
3.4 Peripheral Vascular Disease Epidemiology - Global 13
3.4.1 Treatment Flow Model 13
3.5 Peripheral Vascular Disease: Device Based Treatment Modalities and their Outcomes 14

4 Drug Eluting Balloons - Global Market Characterization 16
4.1 Global Drug Eluting Balloons Market, Revenue ($m), 2003-2010 16
4.2 Global Drug Eluting Balloons Market, Revenue ($m), 2010-2017 17
4.3 Global Drug Eluting Balloons Market, Volume (Units), 2007-2010 18
4.4 Global Drug Eluting Balloons Market, Volume (Units), 2010-2017 19
4.5 Global Drug Eluting Balloons, Market Dynamics 20
4.5.1 Market Drivers 20
4.5.2 Market Restraints 23
4.6 Drug Eluting Balloons - Unmet Need and Opportunities 24
4.6.1 Unmet Need 25
4.6.2 Opportunities 25

5 Drug Eluting Balloons Market, by Country, Revenue ($m), Volume, 2003-2017 26
5.1 Germany Drug Eluting Balloons Market, Revenue ($m), 2003-2010 26
5.2 Germany Drug Eluting Balloons Market, Revenue ($m), 2010-2017 27
5.3 Germany Drug Eluting Balloons Market, Volume, 2003-2010 28
5.4 Germany Drug Eluting Balloons Market, Volume, 2010-2017 29
5.5 France Drug Eluting Balloons Market, Revenue ($m), 2003-2010 30
5.6 France Drug Eluting Balloons Market, Revenue ($m), 2010-2017 31
5.7 France Drug Eluting Balloons Market, Volume, 2003-2010 32
5.8 France Drug Eluting Balloons Market, Volume, 2010-2017 33
5.9 Spain Drug Eluting Balloons Market, Revenue ($m), 2003-2010 34
5.10 Spain Drug Eluting Balloons Market, Revenue ($m), 2010-2017 35
5.11 Spain Drug Eluting Balloons Market, Volume, 2003-2010 36
5.12 Spain Drug Eluting Balloons Market, Volume, 2010-2017 37
5.13 Italy Drug Eluting Balloons Market, Revenue ($m), 2003-2010 38
5.14 Italy Drug Eluting Balloons Market, Revenue ($m), 2010-2017 39
5.15 Italy Drug Eluting Balloons Market, Volume, 2003-2010 40
5.16 Italy Drug Eluting Balloons Market,Volume, 2010-2017 41
5.17 The UK Drug Eluting Balloons Market, Revenue ($m), 2003-2010 42
5.18 The UK Drug Eluting Balloons Market, Revenue ($m), 2010-2017 43
5.19 The UK Drug Eluting Balloons Market, Volume, 2003-2010 44
5.20 The UK Drug Eluting Balloons Market, Volume, 2010-2017 45
5.21 Australia Drug Eluting Balloons Market, Revenue ($m), 2003-2010 46
5.22 Australia Drug Eluting Balloons Market, Revenue ($m), 2010-2017 47
5.23 Australia Drug Eluting Balloons Market, Volume, 2003-2010 48
5.24 Australia Drug Eluting Balloons Market,Volume, 2010-2017 49
5.25 China Drug Eluting Balloons Market, Revenue ($m), 2003-2010 50
5.26 China Drug Eluting Balloons Market, Revenue ($m), 2010-2017 51
5.27 China Drug Eluting Balloons Market, Volume, 2003-2010 52
5.28 China Drug Eluting Balloons Market,Volume, 2010-2017 53
5.29 India Drug Eluting Balloons Market, Revenue ($m), 2003-2010 54
5.30 India Drug Eluting Balloons Market, Revenue ($m), 2010-2017 55
5.31 India Drug Eluting Balloons Market, Volume, 2003-2010 56
5.32 India Drug Eluting Balloons Market,Volume, 2010-2017 57

6 Global Drug Eluting Balloons Market - Company Share Analysis and Key Market Participants 58
6.1 Global Drug Eluting Balloons Market, Company Share (%), 2010 58
6.2 B. Braun 59
6.2.1 Overview 59
6.2.2 Drug Eluting Balloons Portfolio 59
6.3 Eurocor 59
6.3.1 Overview 59
6.4 Invatec 60
6.4.1 Overview 60
6.4.2 Drug Eluting Balloons Portfolio 60
6.5 Aachen Resonance GmbH 61
6.5.1 Overview 61
6.5.2 Drug Eluting Balloons Portfolio 61

7 Global PTCA Coronary Drug Eluting Balloons - Key Marketed Products 62
7.1 SeQuent Please 62
7.1.1 Product Overview and Description 62
7.1.2 Key Technology 62
7.1.3 Past Clinical Studies 62
7.1.4 Ongoing Clinical Trials 65
7.2 DIOR Paclitaxel-Eluting Coronary Balloon Catheter 67
7.2.1 Product Overview and Description 67
7.2.2 Key Technology 67
7.2.3 Past Clinical Studies 67
7.2.4 Ongoing Clinical Trials 69
7.3 Elutax 69
7.3.1 Product Overview and Description 69
7.3.2 Key Technology 69
7.3.3 Past Clinical Studies 70
7.4 Moxy Drug Coated Balloon Catheter 70
7.4.2 Past Clinical Studies 70
7.4.3 Ongoing Clinical Trials 71

8 Global PTA Drug Eluting Balloons Market - Key Marketed Products 72
8.1 Cotavance 72
8.1.1 Product Description 72
8.1.2 Key Technology 72
8.1.3 Past Clinical Studies 72
8.1.4 Ongoing Clinical Trials 73
8.2 IN.PACT Paclitaxel Eluting Balloon Catheter Series 74
8.2.1 Product Description 74
8.2.2 Key Technology 74
8.2.3 Past Clinical Studies 74
8.2.4 Ongoing Clinical Trials 75
8.3 FREEWAY 014 75
8.3.1 Product Description 75
8.3.2 Key Technology 75
8.3.3 Past Clinical Studies 75
8.3.4 Ongoing Clinical Study Results 75

9 Global Drug Eluting Balloons Market - Strategic Pipeline Assessment 76
9.1 Pipeline Technology Assessment 76
9.1.1 Pipeline Technology Assessment for Drug Eluting Balloons by Development Stage for PTCA 76
9.1.2 Pipeline Technology Assessment for Drug Eluting Balloons by Unmet Need 78
9.1.3 Novel Pipeline Technology Assessment for Drug Eluting Balloons 79
9.2 Profiles of Promising Products under Clinical Development 80
9.2.1 Advance 18PTX 80
9.2.2 Genesis DESA Catheter 81
9.2.3 Drug-Eluting PTA Balloon Catheter 81
9.2.4 Drug-Eluting Balloon 81
9.2.5 PTCA Balloon Genistein-Coated Balloon Catheter 82

10 Global Drug Eluting Balloons Market - Strategic Deals Analysis 83
10.1 Key Acquisitions 83
10.1.1 Medtronic Acquired Invatec 83
10.1.2 MEDRAD Completes Acquisition of Possis Medical 83
10.1.3 Opto Circuits Acquired Eurocor 83
10.2 Key Partnerships 84
10.2.1 Cardiovascular Systems Enters into an Agreement with Invatec 84
10.2.2 Maxcor Enters into a Strategic Agreement with Micell Technologies 84
10.2.3 Eurocor Enters into a Distribution Agreement with Goodman 84
10.2.4 MEDRAD Enters into Licensing Agreement with B. Braun Melsungen 85
10.2.5 DSM Biomedical and Caliber Therapeutics Form Partnership 85
10.2.6 Aachen Resonance Enters into a Distribution Agreement with Biotronik 85

11 Appendix 86
11.1 Definitions 87
11.1.1 PTCA Coronary Drug Eluting Balloons (DEB) 87
11.1.2 PTA Peripheral Drug Eluting Balloons (DEB) 87
11.2 Acronyms 87
11.3 Sources 88
11.4 Research Methodology 89
11.4.1 Secondary Research 89
11.4.2 Primary Research 89
11.4.3 Models 90
11.5 Expert Panel 90
11.6 GlobalData Consulting 90
11.7 Contact Us 90
11.8 Disclaimer 91

List of Table


Table 1: Drug Eluting Balloons Market, Global, Revenue ($m), 2003-2010 16
Table 2: Drug Eluting Balloons Market, Global, Revenue ($m), 2010-2017 17
Table 3: Drug Eluting Balloons Market, Global, Volume (Units), 2007-2010 18
Table 4: Drug Eluting Balloons Market, Global, Volume (Units), 2010-2017 19
Table 5: Drug Eluting Balloons Clinical Studies Showing Favorable Results 20
Table 6: Population Aged 65 and Over, Percentage (%), Global, 2010-2030 22
Table 7: Drug Eluting Balloons Clinical Studies Showing Favorable Results 23
Table 8: Drug Eluting Balloons Market, Germany, Revenue ($m), 2003-2010 26
Table 9: Drug Eluting Balloons Market, Germany, Revenue ($m), 20102017 27
Table 10: Drug Eluting Balloons Market, Germany, Volume (Absolute), 2003-2010 28
Table 11: Drug Eluting Balloons Market, Germany, Volume (Absolute), 2010-2017 29
Table 12: Drug Eluting Balloons Market, France, Revenue ($m), 2003-2010 30
Table 13: Drug Eluting Balloons Market, France, Revenue ($m), 2010-2017 31
Table 14: Drug Eluting Balloons Market, France, Volume (Absolute), 2003-2010 32
Table 15: Drug Eluting Balloons Market, France, Volume (Absolute), 2010-2017 33
Table 16: Drug Eluting Balloons Market, Spain, Revenue ($m), 2003-2010 34
Table 17: Drug Eluting Balloons Market, Spain, Revenue ($m), 2010-2017 35
Table 18: Drug Eluting Balloons Market, Spain, Volume (Absolute), 2003-2010 36
Table 19: Drug Eluting Balloons Market, Spain, Volume (Absolute), 2010-2017 37
Table 20: Drug Eluting Balloons Market, Italy, Revenue ($m), 2003-2010 38
Table 21: Drug Eluting Balloons Market, Italy, Revenue ($m), 2010-2017 39
Table 22: Drug Eluting Balloons Market, Italy, Volume (Absolute), 2003-2010 40
Table 23: Drug Eluting Balloons Market, Italy, Volume (Absolute), 2010-2017 41
Table 24: Drug Eluting Balloons Market, The UK, Revenue ($m), 2003-2010 42
Table 25: Drug Eluting Balloons Market, The UK, Revenue ($m), 2010-2017 43
Table 26: Drug Eluting Balloons Market, The UK, Volume (Absolute), 2003-2010 44
Table 27: Drug Eluting Balloons Market, The UK, Volume (Absolute), 2010-2017 45
Table 28: Drug Eluting Balloons Market, Australia, Revenue ($m), 2003-2010 46
Table 29: Drug Eluting Balloons Market, Australia, Revenue ($m), 2010-2017 47
Table 30: Drug Eluting Balloons Market, Australia, Volume (Absolute), 2003-2010 48
Table 31: Drug Eluting Balloons Market, Australia, Volume (Absolute), 2010-2017 49
Table 32: Drug Eluting Balloons Market, China, Revenue ($m), 2003-2010 50
Table 33: Drug Eluting Balloons Market, China, Revenue ($m), 2010-2017 51
Table 34: Drug Eluting Balloons Market, China, Volume (Absolute), 2003-2010 52
Table 35: Drug Eluting Balloons Market, China, Volume (Absolute), 2010-2017 53
Table 36: Drug Eluting Balloons Market, India, Revenue ($m), 2003-2010 54
Table 37: Drug Eluting Balloons Market, India, Revenue ($m), 2010-2017 55
Table 38: Drug Eluting Balloons Market, India, Volume (Absolute), 2003-2010 56
Table 39: Drug Eluting Balloons Market, India, Volume (Absolute), 2010-2017 57
Table 40: Drug Eluting Balloons Market, Global, Key Company Shares (%), 2010 58
Table 41: B. Braun, Drug Eluting Balloons, Pipeline Products 59
Table 42: Eurocor, Drug Eluting Balloons, Pipeline Products 60
Table 43: Invatec, Drug Eluting Balloons, Pipeline Products 61
Table 44: Aachen Resonance, Drug Eluting Balloons, Pipeline Products 61
Table 45: List of Ongoing Clinical Trials, Sequent Please, 2011 65
Table 46: List of Ongoing Clinical Trials, DIOR, 2011 69
Table 47: List of Ongoing Clinical Trials, Moxy Drug Coated Balloon Catheter, 2011 71
Table 48: List of Ongoing Clinical Trials, Cotavance, 2011 73
Table 49: List of Ongoing Clinical Trials, IN.PACT Series 75
Table 50: List of Ongoing Clinical Trials, FREEWAY 75
Table 51: Advance 18 PTX Balloon Catheter - Advance 18PTX Balloon Catheter Study: Treatment of Lesions in Superficial Femoral Artery/Popliteal Artery with a Paclitaxel-Coated Balloon 80

List of Chart


Figure 1: Treatment Flow Model, Drug Eluting Balloons for Treatment of In-Stent Restenosis, Global, 2010 10
Figure 2: Device Based Treatment Modalities for In-Stent Restenosis 11
Figure 3: Treatment Flow Model, Drug Eluting Balloons for Treatment of Peripheral Artery Disease, Global, 2010 13
Figure 4: Device Based Treatment Modalities for Peripheral Vascular Disease 14
Figure 5: Drug Eluting Balloons Market, Global, Revenue ($m), 2003-2010 16
Figure 6: Drug Eluting Balloons Market, Global, Revenue ($m), 2010-2017 17
Figure 7: Drug Eluting Balloons Market, Global, Volume (Units), 2007-2010 18
Figure 8: Drug Eluting Balloons Market, Global, Volume (Units), 2010-2017 19
Figure 9: Population Aged 65 and Over, Percentage (%), Global, 2010-2030 22
Figure 10: Unmet Need and Opportunities Analysis for Drug Eluting Balloons 24
Figure 11: Drug Eluting Balloons Market, Germany, Revenue ($m), 2003-2010 26
Figure 12: Drug Eluting Balloons Market, Germany, Revenue ($m), 2010-2017 27
Figure 13: Drug Eluting Balloons Market, Germany, Volume (Absolute), 2003-2010 28
Figure 14: Drug Eluting Balloons Market, Germany, Volume (Absolute), 2010-2017 29
Figure 15: Drug Eluting Balloons Market, France, Revenue ($m), 2003-2010 30
Figure 16: Drug Eluting Balloons Market, France, Revenue ($m), 2010-2017 31
Figure 17: Drug Eluting Balloons Market, France, Volume (Absolute), 2003-2010 32
Figure 18: Drug Eluting Balloons Market, France, Volume (Absolute), 2010-2017 33
Figure 19: Drug Eluting Balloons Market, Spain, Revenue ($m), 2003-2010 34
Figure 20: Drug Eluting Balloons Market, Spain, Revenue ($m), 2010-2017 35
Figure 21: Drug Eluting Balloons Market, Spain, Volume (Absolute), 2003-2010 36
Figure 22: Drug Eluting Balloons Market, Spain, Volume (Absolute), 2010-2017 37
Figure 23: Drug Eluting Balloons Market, Italy, Revenue ($m), 2003-2010 38
Figure 24: Drug Eluting Balloons Market, Italy, Revenue ($m), 2010-2017 39
Figure 25: Drug Eluting Balloons Market, Italy, Volume (Absolute), 2003-2010 40
Figure 26: Drug Eluting Balloons Market, Italy, Volume (Absolute), 2010-2017 41
Figure 27: Drug Eluting Balloons Market, The UK, Revenue ($m), 2003-2010 42
Figure 28: Drug Eluting Balloons Market, The UK , Revenue ($m), 2010-2017 43
Figure 29: Drug Eluting Balloons Market, The UK, Volume (Absolute), 2003-2010 44
Figure 30: Drug Eluting Balloons Market, The UK, Volume (Absolute), 2010-2017 45
Figure 31: Drug Eluting Balloons Market, Australia, Revenue ($m), 2003-2010 46
Figure 32: Drug Eluting Balloons Market, Australia, Revenue ($m), 2010-2017 47
Figure 33: Drug Eluting Balloons Market, Australia, Volume (Absolute), 2003-2010 48
Figure 34: Drug Eluting Balloons Market, Australia, Volume (Absolute), 2010-2017 49
Figure 35: Drug Eluting Balloons Market, China, Revenue ($m), 2003-2010 50
Figure 36: Drug Eluting Balloons Market, China, Revenue ($m), 2010-2017 51
Figure 37: Drug Eluting Balloons Market, China, Volume (Absolute), 2003-2010 52
Figure 38: Drug Eluting Balloons Market, China, Volume (Absolute), 2010-2017 53
Figure 39: Drug Eluting Balloons Market, India, Revenue ($m), 2003-2010 54
Figure 40: Drug Eluting Balloons Market, India, Revenue ($m), 2010-2017 55
Figure 41: Drug Eluting Balloons Market, India, Volume (Absolute), 2003-2010 56
Figure 42: Drug Eluting Balloons Market, India, Volume (Absolute), 2010-2017 57
Figure 43: Drug Eluting Balloons Market, Global, Company Share (%), 2010 58
Figure 44: Pipeline Technology Assessment for PTCA Coronary Drug Eluting Balloons by Development Stage, Europe, 2011 76
Figure 45: Pipeline Technology Assessment for PTA Drug Eluting Balloons by Development Stage, Europe, 2011 77
Figure 46: Pipeline Technology Assessment for Drug Eluting Balloons by Unmet Need 78

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *